Wednesday, June 10, 2026
🇺🇸 FDA

Drug profile · INN

polysaccharide

polysaccharide is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 20
Pipeline programs 16
News articles 0
Drug details — polysaccharide
Class
—
Route
—
Patents
20
Programs
16
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

polysaccharide is an FDA-listed pharmaceutical active ingredient.

Key facts

INN polysaccharide

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Search pipeline
  1. C1091009 Phase 3 · First Biotech (Australia) · Group B streptococcus (GBS) disease
  2. MEQ00074 Phase 3 · Sanofi Pasteur MSD · Meningococcal Infection
  3. MET55 Phase 3 · Sanofi Pasteur MSD · Meningococcal Immunization
  4. NL79088.041.21 Phase 3 · Disc Medicine · Primary antibody deficiency: - Unclassified antibody deficie
  5. PSK04 Phase 3 · Sanofi-Aventis U.S · Pneumococcal Immunization
  6. V116-013 Phase 3 · MSD Merck Sharp · Pneumococcal disease
  7. 217043 Phase 2 · GSK Glaxo Smith · Infections, Meningococcal
  8. mucoid exopolysaccharide P. aeruginosa immune globulin IV Phase 2 · Ultragenyx UK · Cystic Fibrosis

Related patents

Browse patents

  1. US 11459593

    Dendrobium officinale endophytic fungus strain and extracellular polysaccharide produced thereby, and extraction method and application of extracellular polysaccharide

    Expires Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11369627

    Myrtle polysaccharide P1, the separation method thereof and the use in preparing hypolipidemic drugs therefor

    Expires Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11116830

    Bacterial polysaccharide-conjugated carrier proteins and use thereof

    Expires Mon Sep 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11103601

    Lymph targeting nuclear magnetic contrast agent using brown algae polysaccharide as carrier and preparation method and use thereof

    Expires Mon Aug 26 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 10881684

    Artificial invaplex formulated with deacylated lipopolysaccharide

    Expires Mon Dec 31 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 10864266

    Modified lipopolysaccharide glycoform and method of use

    Expires Mon Dec 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10844098

    Method for preparing bacterial polysaccharide-modified recombinant fusion protein and use of the protein

    Expires Mon Nov 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10744152

    Application of Asarum total polysaccharides in preparation of medicine for treating cough

    Expires Mon Aug 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 10668002

    Anhydrous polysaccharide films

    Expires Mon May 28 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 10525126

    Modified lipopolysaccharide glycoform and method of use

    Expires Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 9827295

    Methods to treat mucopolysaccharide type I or deficiency in alpha-L-iduronidase using a recombinant adeno-associated virus encoding alpha-L-iduronidase

    Expires Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 9737477

    Anti-aging dietary composition containing polysaccharides derived from ginseng and tuber fleeceflower root

    Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 9677052

    Modified lipopolysaccharide glycoform and method of use

    Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 9662349

    Dietary composition having mixed polysaccharides derived from lucid ganoderma, lycium barbarum and polygonatum sibiricum and method of its preparation

    Expires Mon May 25 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9629385

    Dietary composition containing cistanche deserticola polysaccharide with inhibitory effects on colon cancer

    Expires Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9474795

    Polysaccharide-protein conjugate vaccines

    Expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9200024

    Production of defined monodisperse heparosan polymers and unnatural polymers with polysaccharide synthases

    Expires Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9198976

    Polysaccharide-protein conjugate vaccines

    Expires Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 9173931

    Process for preparing polysaccharide-protein conjugate vaccines

    Expires Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9011925

    Method for preparing polysaccharide nanocomposite particles and uses of the same

    Expires Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is polysaccharide?

polysaccharide is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.